You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
FAQ
Education
Download
About us
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsDetails

《新股消息》加科思药业(01167.HK)今日起招股 入场费4,242.32元

阿思达克 12-09 09:43
临床阶段制药公司加科思药业(01167.HK)公布招股详情，计划发售9,647.61万股股份，当中10%在港公开发售，招股价介乎每股12至14元，每手300股，入场费为4,242.32元。由今日(9日)至下周一(14日)公开招股，预计於12月21日上市。高盛及中金为联席保荐人。

公司为上市引入6名基石投资者，包括LAV Funds、Matthews Funds、哈德逊湾资本、Octagon Investments等，合共认购6,000万美元股份。

以招股价中位数13元计，公司预计集资所得款项净额约为11.71亿元，当中88%将主要用於产品的临床开发及商业化；8%将用於建造符合GMP标准的内部生产设施；余下4%将作为一般企业及营运资金用途。

Relevant Recommendation
Business Collaboration
Account Opening

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
Contact Us
Customer Service Hotline︰+852 3018 4526
Email︰cs@usmarthk.com
Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong
WhatsApp︰+852 5989 2641
Join the Community：
uSMART-Facebook-Page
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Copyright © 2022 uSMART . All Rights Reserved.